Issledovanie urovnya mozgovogo natriyureticheskogo peptida na vysote fizicheskoy nagruzki u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu i sokhrannoy sistolicheskoy funktsiey levogo zheludochka
Gennadiy Efimovich Gendlin , S N Borisov , G I Storozhakov , A V Melekhov
Russian Medicine ›› 2010, Vol. 16 ›› Issue (5) : 8 -11.
Issledovanie urovnya mozgovogo natriyureticheskogo peptida na vysote fizicheskoy nagruzki u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu i sokhrannoy sistolicheskoy funktsiey levogo zheludochka
The measurement of the concentration of brain natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) has currently enjoyed wide application in the diagnosis of chronic heart failure (CHF); however, the use of these markers for the diagnosis of CHF with preserved left ventricular (LV) systolic function has been inadequately studied. The purpose of the investigation was to study the level of NT-proBNP at peak exercise in patients with CHF and preserved LV systolic function as compared with changes in NT-proBNP concentrations during exercise in healthy individuals. The serum concentration of NT-proBNP was determined in 22 patients with CHF and preserved LV systolic function and in 15 subjects without CHF at rest and peak treadmill exercise testing by the standard Bruce protocol. In the CHF group, the increment in NT-proBNP at peak exercise (d NT-proBNP) was 3.2 times greater than that in the control group (p = 0.02) and the percentage increase in NT-proBNP (d NT-proBNP/NT-proBNP at rest 100%) was 3.4 times higher than that in the controls (p = 0.02). In the patients with CHF, the ratio of d NT-proBNP to exercise duration was 5.4 times greater than that in the subjects without CHF (p = 0.003) and that of percentage increase in NT-proBNP to exercise duration was 7 times higher than that in the controls (p = 0.004). The absolute and percentage increments in NT = proBNP correlated with exercise duration (p = 0.009 and p = 0.035, respectively); the percentage increase in NT-proBNP also correlated with ejection fraction (p = 0.016).
chronic heart failure / brain natriuretic peptide levels
| [1] |
Волкова С. Ю. // Сердечная недостаточность. - 2008. - № 1. - С. 25-30. |
| [2] |
Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр) / Под ред. Ф. Т. Агеева и др. // Сердечная недостаточность. - 2009. - № 2. - С. 64-103. |
| [3] |
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // Circulation. - 2001. - Vol. 104. - P. 2996-3007. |
| [4] |
How to Diagnose Diastolic Heart Failure: a Consensus Statement on the Diagnosis of Heart Failure with Normal Left Ventricular Ejection Fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology // Eur. Heart J. - 2007. - Vol. 28, N 20. - P. 2539-2550. |
| [5] |
Kazanegra R., Van Cheng, Garcia A. et al. // J. Car. Fail. - 2001. - Vol. 7. - P. 21-29. |
| [6] |
Maeda K., Tsutamoto T., Wada A. et al. // Am. Heart J. - 1998. - Vol. 135. - P. 825-832. |
| [7] |
Mottram P. M., Haluska B. A., Marwick T. H. // Am. Heart J. - 2004. - Vol. 148, N 2. - P. 365-370. |
| [8] |
The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005) // Eur. Heart J. - 2005. - Vol. 26. |
| [9] |
Vanderheyden M., Bartunec J. // Eur. J. Heart Fail. - 2004. - Vol. 3. - P. 261-267. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
